|
J Biol Chem, Vol. 273, Issue 35, 22672-22680, August 28, 1998
Specificity of Prohormone Convertase 2 on Proenkephalin and
Proenkephalin-related Substrates
Karla
Johanning ,
Maria A.
Juliano§,
Luiz
Juliano§,
Claude
Lazure ,
Nazarius S.
Lamango ,
Donald
F.
Steiner**, and
Iris
Lindberg
From the Department of Biochemistry and Molecular
Biology, Louisiana State University Medical Center, School of
Medicine, New Orleans, Louisiana 70112, the § Department
of Biophysics, Escola Paulista de Medicina, Rua Tres de Maio 100, 04044-020, Sao Paulo, Brazil, the Neuropeptide Structure and
Metabolism Laboratory, Institut de Recherches Cliniques de
Montreal, Montreal, Quebec, Canada 2W 1R7, and the ** Howard Hughes
Medical Institute and Department of Biochemistry, University of Chicago
Medical School, Chicago, Illinois 60637
In the central and peripheral nervous
systems, the neuropeptide precursor proenkephalin must be
endoproteolytically cleaved by enzymes known as prohormone convertases
1 and 2 (PC1 and PC2) to generate opioid-active enkephalins. In this
study, we have investigated the specificity of recombinant mouse PC2
for proenkephalin-related internally quenched (IQ) peptides, for
methylcoumarin amide-based fluorogenic peptides, and for recombinant
rat proenkephalin. IQ peptides exhibited specificity constants
(kcat/Km) between 9.4 × 104 M 1 s 1
(Abz-Val-Pro-Arg-Met-Glu-Lys-Arg-Tyr-Gly-Gly-Phe-Met-Gln-EDDnp; where
Abz is ortho-aminobenzoic acid and EDDnp is
N-(2,4-dinitrophenyl)ethylenediamine)) and 0.24 × 104 M 1 s 1
(Abz-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-EDDnp), with the
peptide B to Met-enk-Arg-Phe cleavage preferred (Met-enk is
met-enkephalin). Fluorogenic substrates with P1, P2, and P4 basic amino
acids were hydrolyzed with specificity constants ranging between
2.0 × 103 M 1
s 1 (Ac-Orn-Ser-Lys-Arg-MCA; where MCA is methylcoumarin
amide) and 1.8 × 104 M 1
s 1 (<Glu-Arg-Thr-Lys-Arg-MCA; where <Glu is
pyroglutamic acid). Substrates containing only a single basic residue
were not appreciably hydrolyzed, and substrates lacking a P4 Arg
exhibited kcat of less than 0.05 s 1. Substitution of ornithine for Lys at the P4 position
did not significantly affect the kcat but
increased the Km 2-fold. Data from both sets of
fluorogenic substrates supported the contribution of a P4 Arg to PC2
preference. Analysis of proenkephalin reaction products using
immunoblotting and gel permeation chromatography demonstrated that PC2
can directly cleave proenkephalin and that the generation of small
opioid peptides from intermediates is mediated almost entirely by PC2
rather than by PC1. These results are in accord with the analysis of
PC2 knock-out brains, in which the amounts of three mature enkephalins
were depleted by more than three-quarters.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S.-R. Hwang, C. Garza, C. Mosier, T. Toneff, E. Wunderlich, P. Goldsmith, and V. Hook
Cathepsin L Expression Is Directed to Secretory Vesicles for Enkephalin Neuropeptide Biosynthesis and Secretion
J. Biol. Chem.,
March 30, 2007;
282(13):
9556 - 9563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Scamuffa, F. Calvo, M. Chretien, N. G. Seidah, and A.-M. Khatib
Proprotein convertases: lessons from knockouts
FASEB J,
October 1, 2006;
20(12):
1954 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pasquato, P. Pullikotil, M.-C. Asselin, M. Vacatello, L. Paolillo, F. Ghezzo, F. Basso, C. Di Bello, M. Dettin, and N. G. Seidah
The Proprotein Convertase SKI-1/S1P: IN VITRO ANALYSIS OF LASSA VIRUS GLYCOPROTEIN-DERIVED SUBSTRATES AND EX VIVO VALIDATION OF IRREVERSIBLE PEPTIDE INHIBITORS
J. Biol. Chem.,
August 18, 2006;
281(33):
23471 - 23481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Kacprzak, M. E. Than, L. Juliano, M. A. Juliano, W. Bode, and I. Lindberg
Mutations of the PC2 Substrate Binding Pocket Alter Enzyme Specificity
J. Biol. Chem.,
September 9, 2005;
280(36):
31850 - 31858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. X. Cawley, J. Zhou, J. M. Hill, D. Abebe, S. Romboz, T. Yanik, R. M. Rodriguiz, W. C. Wetsel, and Y. P. Loh
The Carboxypeptidase E Knockout Mouse Exhibits Endocrinological and Behavioral Deficits
Endocrinology,
December 1, 2004;
145(12):
5807 - 5819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dey, C. Norrbom, X. Zhu, J. Stein, C. Zhang, K. Ueda, and D. F. Steiner
Furin and Prohormone Convertase 1/3 Are Major Convertases in the Processing of Mouse Pro-Growth Hormone-Releasing Hormone
Endocrinology,
April 1, 2004;
145(4):
1961 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Laurent, L. Jaubert-Miazza, R. Desjardins, R. Day, and I. Lindberg
Biosynthesis of Proopiomelanocortin-Derived Peptides in Prohormone Convertase 2 and 7B2 Null Mice
Endocrinology,
February 1, 2004;
145(2):
519 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vincent, Y. Guz, M. Rozenberg, G. Webb, M. Furuta, D. Steiner, and G. Teitelman
Abrogation of Protein Convertase 2 Activity Results in Delayed Islet Cell Differentiation and Maturation, Increased {alpha}-Cell Proliferation, and Islet Neogenesis
Endocrinology,
September 1, 2003;
144(9):
4061 - 4069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yasothornsrikul, D. Greenbaum, K. F. Medzihradszky, T. Toneff, R. Bundey, R. Miller, B. Schilling, I. Petermann, J. Dehnert, A. Logvinova, et al.
Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter
PNAS,
August 5, 2003;
100(16):
9590 - 9595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS
Curbing activation: proprotein convertases in homeostasis and pathology
FASEB J,
July 1, 2003;
17(10):
1215 - 1227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dey, X. Xhu, R. Carroll, C. W. Turck, J. Stein, and D. F. Steiner
Biological Processing of the Cocaine and Amphetamine-regulated Transcript Precursors by Prohormone Convertases, PC2 and PC1/3
J. Biol. Chem.,
April 18, 2003;
278(17):
15007 - 15014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Cornwall, A. Cameron, I. Lindberg, D. M. Hardy, N. Cormier, and N. Hsia
The Cystatin-Related Epididymal Spermatogenic Protein Inhibits the Serine Protease Prohormone Convertase 2
Endocrinology,
March 1, 2003;
144(3):
901 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhu, A. Zhou, A. Dey, C. Norrbom, R. Carroll, C. Zhang, V. Laurent, I. Lindberg, R. Ugleholdt, J. J. Holst, et al.
Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects
PNAS,
August 6, 2002;
99(16):
10293 - 10298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Rockwell and R. S. Fuller
Specific Modulation of Kex2/Furin Family Proteases by Potassium
J. Biol. Chem.,
May 10, 2002;
277(20):
17531 - 17537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Laurent, A. Kimble, B. Peng, P. Zhu, J. E. Pintar, D. F. Steiner, and I. Lindberg
Mortality in 7B2 null mice can be rescued by adrenalectomy: Involvement of dopamine in ACTH hypersecretion
PNAS,
February 14, 2002;
(2002)
261715099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Li, E. Jansen, G. A. Brent, and T. C. Friedman
Regulation of prohormone convertase 1 (PC1) by thyroid hormone
Am J Physiol Endocrinol Metab,
January 1, 2001;
280(1):
E160 - E170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. V. Apletalina, L. Muller, and I. Lindberg
Mutations in the Catalytic Domain of Prohormone Convertase 2 Result in Decreased Binding to 7B2 and Loss of Inhibition with 7B2 C-terminal Peptide
J. Biol. Chem.,
May 5, 2000;
275(19):
14667 - 14677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.S.H. Yeo, I.S. Farooqi, B.G. Challis, R.S. Jackson, and S. O'Rahilly
The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models
QJM,
January 1, 2000;
93(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zhou, G. Webb, X. Zhu, and D. F. Steiner
Proteolytic Processing in the Secretory Pathway
J. Biol. Chem.,
July 23, 1999;
274(30):
20745 - 20748.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Apletalina, J. Appel, N. S. Lamango, R. A. Houghten, and I. Lindberg
Identification of Inhibitors of Prohormone Convertases 1 and 2 Using a Peptide Combinatorial Library
J. Biol. Chem.,
October 9, 1998;
273(41):
26589 - 26595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Muller, A. Cameron, Y. Fortenberry, E. V. Apletalina, and I. Lindberg
Processing and Sorting of the Prohormone Convertase 2 Propeptide
J. Biol. Chem.,
December 8, 2000;
275(50):
39213 - 39222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Goumon, K. Lugardon, P. Gadroy, J.-M. Strub, I. D. Welters, G. B. Stefano, D. Aunis, and M.-H. Metz-Boutigue
Processing of Proenkephalin-A in Bovine Chromaffin Cells. IDENTIFICATION OF NATURAL DERIVED FRAGMENTS BY N-TERMINAL SEQUENCING AND MATRIX-ASSISTED LASER DESORPTION IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY
J. Biol. Chem.,
December 1, 2000;
275(49):
38355 - 38362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mzhavia, Y. Berman, F.-Y. Che, L. D. Fricker, and L. A. Devi
ProSAAS Processing in Mouse Brain and Pituitary
J. Biol. Chem.,
February 23, 2001;
276(9):
6207 - 6213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Furuta, A. Zhou, G. Webb, R. Carroll, M. Ravazzola, L. Orci, and D. F. Steiner
Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice
J. Biol. Chem.,
July 13, 2001;
276(29):
27197 - 27202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Laurent, A. Kimble, B. Peng, P. Zhu, J. E. Pintar, D. F. Steiner, and I. Lindberg
Mortality in 7B2 null mice can be rescued by adrenalectomy: Involvement of dopamine in ACTH hypersecretion
PNAS,
March 5, 2002;
99(5):
3087 - 3092.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|